作者: Pingping He , Xinping Ouyang , Shouhong Zhou , Weidong Yin , Chaoke Tang
DOI: 10.1016/J.YHBEH.2013.04.009
关键词: Alzheimer's disease 、 Receptor 、 Hippocampal formation 、 Piromelatine 、 Serotonin 、 Neuroprotection 、 Neuroscience 、 Agonist 、 Psychology 、 Melatonin
摘要: Previous studies have shown that melatonin is implicated in modulating learning and memory processing. Melatonin also exerts neuroprotective activities against Aβ-induced injury vitro vivo. Neu-P11 (piromelatine, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-4-oxo-4H-pyran-2-carboxamide) a novel (MT1/MT2) receptor agonist serotonin 5-HT1A/1D recently developed for the treatment of insomnia. In present study we firstly investigated whether enhance performance object recognition (NOR) task rats, then assessed improve neuronal cognitive impairment rat model Alzheimer' disease (AD) induced by intrahippocampal Aβ(1-42) injection. The results showed single morning or afternoon administration enhanced measured at 4 24h after training. was effective facilitating effects only when administered afternoon. Further injection resulted hippocampal cellular loss, as well decreased ability Y maze NOR tasks rats. but not attenuated loss AD model. current data suggest may serve agent AD.